<?xml version="1.0" encoding="utf-8"?>
<Document>
  <Meeting_name> A multicenter phase II trial of adjuvant erlotinib in patients with resected non-small cell lung cancer (NSCLC) and mutations in the epidermal growth factor receptor (EGFR)</Meeting_name>
  <Doc_title> A multicenter phase II trial of adjuvant erlotinib in patients with resected non-small cell lung cancer (NSCLC) and mutations in the epidermal growth factor receptor (EGFR)</Doc_title>
  <Background>['Background', ' Adjuvant chemotherapy for']</Background>
</Document>
